The World Health Organization in its 2019 research survey has stated that in the last decade due to needle stick injury approximately 2 million healthcare professionals experienced percutaneous exposure to infectious diseases such as Hepatitis B and C virus, and HIV. Earlier, prefilled syringes were featured as add on safety devices, but technological advancement in the design aspect has introduced inbuilt safety mechanism. Unilife Corporation was the first manufacturer to market prefilled syringes with integrated safety features. Manufacturers are presently focusing on developing prefilled syringes with auto retractable needle technology and adopting integrated passive safety mechanism for prefilled syringes needle-stick safety.

The market scope for the report prefilled syringes includes types such as disposable prefilled syringes and reusable prefilled syringes. The materials considered for the report is sub segmented as plastic prefilled syringes and glass prefilled syringes. The application of prefilled syringes is prevalent in major areas such as diabetes, anaphylaxis, rheumatoid arthritis and others (biotech drugs and vaccines).

In the geography segment the data forecast and market estimation is covered to understand the market trend prevailing in the major countries.

Critical parameters such as product portfolio, geographical presence and inception helps in the determination of top 3 countries and in mapping the currently existing competition in prefilled syringes market. The company profiles suffices us with the latest technology adopted by the premier players and recent merger and acquisition influencing the business milieu of global prefilled syringes market. The manufacturers seeking prime position in the global prefilled syringes market are Bayer Healthcare, Gerresheimer AG, Biocon, Becton, Dickinson & Company, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation and Vetter Pharma International GmbH.

Prefilled syringes have potential demand among healthcare professionals due offered advantages such as convenient drug delivery method and precise unit dose medication. Disposable prefilled syringes have excellent market on the account of increasing public awareness regarding needle safety and reduction in risk of contamination and infection as the syringes are disposed off immediately after single use. Reusable prefilled syringes are widely employed for drug delivery for chronic diseases as they are available as durable glass and plastic graduated cylinders to adjust the IV bolus and easy to dismantle, clean and autoclavable at 2730F. Important players in prefilled syringes market are Bayer Healthcare, Biocon, Becton, Dickinson & Company, Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation and Vetter Pharma International GmbH.

The conventional syringe vial combination has been replaced by prefilled syringes as they are helpful to healthcare professionals due to the ease of drug injection procedures and time saving. In addition, the decreasing manufacturing cost of prefilled syringes and their increasing demand from homecare and institutional patients for self-injection will drive the prefilled syringes market. Diabetes segment represents the superior share in prefilled syringes market owing to the rising prevalence of diabetes and increasing demand for prefilled insulin syringes for its excellent results in patients suffering with type 1 diabetes. Anaphylaxis segment employs prefilled syringes under emergency situations arisen due to anaphylactic shock reactions. Prefilled syringes are used by the pharmaceutical companies to store biotech drugs and vaccines that have stability issues while transferring them from vials to syringes.

The Centers for Disease Control and Prevention has stated in its 2019 report that approximately eighty six percent of the United States annual healthcare expenditures are for the treatment of people suffering with chronic ailments. North America is the leader in global prefilled syringe market as a result of increasing number of citizens suffering with chronic ailments and enhanced spending in the research and development of prefilled syringes. In Europe, increasing demand for prefilled syringes in homecare settings and domicile of key players pioneering in manufacture of vaccines and biosimilars will drive its market. Asia Pacific reflects substantial market opportunity on account of welcoming regulatory environment for prefilled syringes and government spending in developing healthcare infrastructure for the middle- and low-income people to avail medication for chronic ailments. Provision of healthcare aid by agencies such as the World Health Organization and Red Cross, and health awareness campaign conducted by premier player will proliferate the prefilled syringes market in Middle East and Africa and Latin America.

Prefilled syringe materials have 2 value additions in healthcare drug delivery: the primary packaging aspects of syringe manufacturing provides assurance that there is no untoward effect on the drug shelf life, strength and purity; and convenience in administering the appropriate amount of the medication to the patient. Glass syringes have advantages such as optical clarity in which medication volumes are read to the point as the plunger is parallel with the calibration in syringe, and possess excellent thermal and chemical resistance properties. The drawbacks associated with glass syringes are breakage, potential surface reactivity, leaching and particulate contamination. Plastic syringes made from cyclic polyolefin resin are gaining tremendous popularity among healthcare professionals. The inherent features of plastic syringes with break resistance, decreased surface reactivity, reduced drug adsorption and compatible with high and low pH drug solutions.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Prefilled Syringes market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Prefilled Syringes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Prefilled Syringes market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Prefilled Syringes market?
• Which is the largest regional market for Prefilled Syringes market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Prefilled Syringes market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Prefilled Syringes market worldwide?